Title |
ClinGen’s RASopathy Expert Panel consensus methods for variant interpretation
|
---|---|
Published in |
Genetics in Medicine, March 2018
|
DOI | 10.1038/gim.2018.3 |
Pubmed ID | |
Authors |
Bruce D Gelb, Hélène Cavé, Mitchell W Dillon, Karen W Gripp, Jennifer A Lee, Heather Mason-Suares, Katherine A Rauen, Bradley Williams, Martin Zenker, Lisa M Vincent, for the ClinGen RASopathy Working Group |
Abstract |
PurposeStandardized and accurate variant assessment is essential for effective medical care. To that end, Clinical Genome (ClinGen) Resource clinical domain working groups (CDWGs) are systematically reviewing disease-associated genes for sufficient evidence to support disease causality and creating disease-specific specifications of American College of Medical Genetics and Genomics-Association for Molecular Pathology (ACMG-AMP) guidelines for consistent and accurate variant classification.MethodsThe ClinGen RASopathy CDWG established an expert panel to curate gene information and generate gene- and disease-specific specifications to ACMG-AMP variant classification framework. These specifications were tested by classifying 37 exemplar pathogenic variants plus an additional 66 variants in ClinVar distributed across nine RASopathy genes.ResultsRASopathy-related specifications were applied to 16 ACMG-AMP criteria, with 5 also having adjustable strength with availability of additional evidence. Another 5 criteria were deemed not applicable. Key adjustments to minor allele frequency thresholds, multiple de novo occurrence events and/or segregation, and strength adjustments impacted 60% of variant classifications. Unpublished case-level data from participating laboratories impacted 45% of classifications supporting the need for data sharing.ConclusionRAS-specific ACMG-AMP specifications optimized the utility of available clinical evidence and Ras/MAPK pathway-specific characteristics to consistently classify RASopathy-associated variants. These specifications highlight how grouping genes by shared features promotes rapid multigenic variant assessment without sacrificing specificity and accuracy.GENETICS in MEDICINE advance online publication, 1 March 2018; doi:10.1038/gim.2018.3. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 11 | 28% |
United Kingdom | 6 | 15% |
Saudi Arabia | 1 | 3% |
India | 1 | 3% |
Bosnia and Herzegovina | 1 | 3% |
Turkey | 1 | 3% |
Cyprus | 1 | 3% |
Taiwan | 1 | 3% |
France | 1 | 3% |
Other | 4 | 10% |
Unknown | 12 | 30% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 20 | 50% |
Scientists | 19 | 48% |
Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 132 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 27 | 20% |
Other | 25 | 19% |
Student > Master | 12 | 9% |
Student > Ph. D. Student | 10 | 8% |
Student > Bachelor | 9 | 7% |
Other | 14 | 11% |
Unknown | 35 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 38 | 29% |
Agricultural and Biological Sciences | 22 | 17% |
Medicine and Dentistry | 21 | 16% |
Neuroscience | 3 | 2% |
Computer Science | 2 | 2% |
Other | 6 | 5% |
Unknown | 40 | 30% |